Drugs / grass pollen allergen extract
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial · 1 met primary | ||||||
| Phase 1 | NCT00619827 | Sep 2007 → Mar 2008 | seasonal allergic rhinitis | Stallergenes Greer | Completed | Met primary |
| Phase 2/31 trial · 1 met primary | ||||||
| Phase 2/3 | NCT00367640 | Nov 2004 → Sep 2005 | allergic disease | Stallergenes Greer | Completed | Met primary |
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00409409 | Dec 2006 → Sep 2007 | allergic disease | Stallergenes Greer | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | grass pollen allergen extract | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00409409 ↗ |
| Route | Other | “administered sublingually using a once-daily tablet formulation” PMID 17935764 ↗ Nov 2007 |